eli lilly sues compounders for selling unapproved copies of tirzepatide Novo Nordisk filed a lawsuit against & Co. accusing the manufacturer weight-loss drug Zepbound of deceptive advertising allegedly comparing high doses of its drug to low doses of Eli Lilly's Popular Weight Loss
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14





















